Medicine and Dentistry
Hepatocellular Carcinoma
100%
Liver Cirrhosis
54%
Liver Transplantation
35%
Barrett Esophagus
30%
Acute Liver Failure
29%
Malignant Neoplasm
22%
Disease
21%
Liver Graft
20%
Liver Disease
20%
Neoplasm
20%
Gastroesophageal Reflux
18%
Hepatitis C
15%
Hepatitis C Virus
14%
Transplantation
13%
Primary Biliary Cirrhosis
13%
Nonalcoholic Fatty Liver
12%
Biological Marker
12%
Prevalence
12%
Infection
11%
Liver Cancer
10%
Fibrosis
10%
Overall Survival
10%
Inflammatory Bowel Disease
10%
Meta-Analysis
10%
Liver Injury
10%
Colonoscopy
10%
Diagnosis
10%
Odds Ratio
9%
Hazard Ratio
9%
Esophagus
9%
Endoscopy
9%
Magnetic Resonance Imaging
9%
Systematic Review
9%
Health Care Cost
9%
Symptom
8%
Biopsy
8%
Proton-Pump Inhibitor
8%
Colorectal Cancer
7%
Chronic Hepatitis C
7%
Cohort Analysis
7%
Esophageal Adenocarcinoma
7%
Bleeding
6%
Surgery
6%
Reflux
6%
Paracetamol
6%
Antivirus Agent
6%
Fatty Liver
6%
Hepatitis B Virus
6%
Dysplasia
6%
Logistic Regression Analysis
6%
Colorectal Cancer Screening
6%
Combination Therapy
6%
Recurrent Disease
6%
Ursodeoxycholic Acid
6%
Endoscopic Retrograde Cholangiopancreatography
5%
Hepatic Encephalopathy
5%
Antiviral Therapy
5%
Cancer Staging
5%
Alpha-Fetoprotein
5%
Cancer
5%
Adverse Event
5%
Drug Therapy
5%
Esophageal Cancer
5%
Patient with Inflammatory Bowel Disease
5%
Retrospective Cohort Study
5%
Health System
5%
Hepatitis B
5%
Chronic Liver Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
57%
Acute Liver Failure
28%
Liver Cirrhosis
27%
Hepatitis C
16%
Disease
16%
Paracetamol
15%
Mouse
13%
Biological Marker
12%
Hepatitis C Virus
12%
Malignant Neoplasm
12%
Nonalcoholic Fatty Liver
11%
Liver Injury
11%
Chronic Hepatitis C
11%
Liver Disease
10%
Neoplasm
10%
Prevalence
9%
Barrett Esophagus
9%
Fibrosis
9%
Primary Biliary Cirrhosis
8%
Inflammatory Bowel Disease
8%
Infection
8%
Ribavirin
8%
Colorectal Cancer
8%
Sterol
8%
Interferon
8%
Antivirus Agent
7%
Overall Survival
6%
Hepatitis B Virus
6%
Low Density Lipoprotein Receptor
6%
Ethanol
6%
Toxic Hepatitis
6%
Proton Pump Inhibitor
6%
Inflammation
6%
Hepatitis B
6%
Combination Therapy
6%
Non-Steroidal Anti-Inflammatory Drug
6%
Acetylsalicylic Acid
5%
Adverse Event
5%
Cohort Study
5%
Low Density Lipoprotein Cholesterol
5%
Bile Acid
5%
Peginterferon
5%
Clinical Trial
5%
Recurrent Disease
5%
Gastroesophageal Reflux
5%
Low Density Lipoprotein
5%
Hepatotoxicity
5%
Virus Hepatitis
5%
Ursodeoxycholic Acid
5%
Chronic Hepatitis B
5%
Placebo
5%
Keyphrases
Hepatocellular Carcinoma
41%
Cirrhosis
27%
Liver Transplantation
20%
Barrett's Esophagus
18%
Acute Liver Failure
18%
Liver
17%
Hepatocellular Carcinoma Surveillance
15%
United States
14%
Cholesterol
11%
Confidence Interval
9%
Gastroesophageal Reflux Disease
8%
Liver Disease
7%
Hepatitis C
7%
Sterol Regulatory Element-binding protein-1c (SREBP-1c)
7%
Primary Biliary Cholangitis
7%
Non-alcoholic Fatty Liver Disease (NAFLD)
6%
Inflammatory Bowel Disease
6%
Meta-analysis
6%
Overall Survival
6%
Alpha-fetoprotein
6%
Low-density Lipoprotein
6%
Ultrasound
5%
Early Hepatocellular Carcinoma
5%
Clinical Outcomes
5%
Liver Transplant Recipients
5%
Odds Ratio
5%
Systematic Meta-analysis
5%